Baylies v. Doberstein, 97-6046 (2003)

CourtSuperior Court of Rhode Island
DecidedSeptember 4, 2003
DocketC.A. No. PC97-6046
StatusPublished

This text of Baylies v. Doberstein, 97-6046 (2003) (Baylies v. Doberstein, 97-6046 (2003)) is published on Counsel Stack Legal Research, covering Superior Court of Rhode Island primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Baylies v. Doberstein, 97-6046 (2003), (R.I. Ct. App. 2003).

Opinion

DECISION
Before this Court is the motion of Frank P. Baylies, Rosemary Baylies, Individually and as Mother and next Friend of Collin James Baylies, Geoffrey David Baylies, and Laura Rose Baylies (the "Plaintiffs") for a new trial pursuant to Rule 59 of the Rhode Island Superior Court Rules of Civil Procedure. Curtis Doberstein, M.D. ("Defendant") objects to the Plaintiffs' motion and renews his motion for judgment as a matter of law pursuant to Rule 50(b). For the reasons set forth below, this Court denies the Plaintiffs' motion for a new trial and denies the Defendant's renewed motion for judgment as a matter of law.

FACTS AND TRAVEL
On April 26, 1996, Frank P. Baylies was admitted to the Rhode Island Hospital, under the care of Dr. Curtis Doberstein, for a posterior fossa craniotomy resection of a right acoustic neuroma. Prior to his surgery, Mr. Baylies had undergone three preoperative blood studies, each of which showed that he had an elevated prothrombin time (PT). His elevated PT level was likely caused by a deficiency in Factor VII, one of the clotting factors of his blood. On the morning of the surgery, Mr. Baylies' PT was 16.3 seconds. The control at the Rhode Island Hospital was 12 seconds. Mr. Baylies received transfusions of fresh, frozen plasma in order to bring his Factor VII to within a normal range. The half-life of Factor VII, which is replenished by the transfusions, is no more than five or six hours after it is replaced.

Within twelve to eighteen hours following the surgery, Mr. Baylies started bleeding inside his skull. This complication of intracranial bleeding required two emergency craniotomies to evacuate the hematomas. On December 17, 1997, the Plaintiffs filed a medical malpractice action against Dr. Doberstein and Rhode Island Hospital, claiming that their negligence led to Mr. Baylies' post-surgical complications.

On February 3, 2003, all claims against Rhode Island Hospital were dismissed with prejudice. On February 4, 2003, a Superior Court jury began hearing testimony surrounding the facts that led to the civil negligence action against the Defendant, Dr. Doberstein. Dr. Michael Laposata, a coagulation specialist from Massachusetts General Hospital, and not one of Mr. Baylies' treating physicians, testified on behalf of the Plaintiffs that the postoperative bleed was caused by the inadequacy of Factor VII within Mr. Baylies' blood. Dr. Laposata rendered an opinion that Dr. Doberstein's treatment of plasma transfusions was inadequate to enable Mr. Baylies' blood to clot normally, both as to frequency and the sufficiency of dosage, based on the patient's elevated PT levels. Dr. Laposata testified as to the "unique program" at Massachusetts General Hospital, which provides an automatic expert opinion whenever evaluations are performed that involve specialized testing in coagulation. He testified that he had tested Mr. Baylies, his parents, and his children and found that there was a Factor VII deficiency that was heterozygous. He acknowledged that he had written an article that indicated that there was no bleeding risk in heterozygous deficiency, with rare exceptions. He further testified that the present case did not fall into one of the rare exception categories. Dr. Laposata also acknowledged that he had written that the risk of bleeding "appears to be very low when the prothrombin time and the partial thromboplastin time are only mildly elevated and that means 1 ½ times the control."

The Defendant's neurosurgery expert, Dr. Long, opined that the Defendant's treatment of Mr. Baylies' elevated PT levels with two units of fresh frozen plasma before surgery, one unit during surgery, and two units shortly before the discovery of his first postoperative bleed, was adequate to deal with the issue of postoperative bleeding. Dr. Hellwig, the Defendant's hematology expert, testified that he would have prescribed the exact same course of administering fresh frozen plasma as that which Dr. Doberstein administered in the present case. Doctors Crowley, Long, Doberstein, de Lotbinieiere, and Ellman all offered testimony as to the appropriateness of the treatment. Drs. de Lotbinieiere and Crowley were particularly compelling in their assessment that the Defendant's conduct more than comported with the standard of care. Both Drs. de Lotbinieiere and Crowley withstood cross-examination without difficulty.

Dr. Leonard Ellman, a board certified hematologist from Massachusetts General Hospital, testified for the Defendant that he was surprised that he did not find information concerning Dr. Laposata's specific testing of Mr. Baylies, his parents, and his children in the hospital computer system. Though he did not question Dr. Laposata's integrity, Dr. Ellman characterized the testing as an informal set of tests that were not handled in the conventional manner and not officially entered into the hospital's medical record-keeping system. He stated that the program at Massachusetts General Hospital, which allows Dr. Laposata to provide an interpretation after testing, contradicts Medicare regulations because Medicare requires that a consultation must be requested by the requesting doctor. Though he did not have any supporting documentation, Dr. Ellman testified that to do private testing and not enter the results in the hospital computer system violates the rules and regulations of Massachusetts General Hospital.

After twelve days of testimony, the trial concluded on February 25, 2003 with the jury returning a verdict in favor of the Defendant. After entry of judgment, the Plaintiffs filed a timely motion for a new trial with this Court. The Plaintiffs contend that their causation expert, Dr. Laposata, was wrongfully made to look like a fraud because of the "prejudicial, inflammatory, [and] irrelevant testimony" of Dr. Ellman, an expert witness on behalf of the Defendant, during his cross-examination, thus prejudicing the jury against them. The Defendant counters that Dr. Laposata's testimony was not unduly prejudicial and, furthermore, was inconsistent with his own writings and the testimony and actions of others who cared for Mr. Baylies. Additionally, the Defendant asks this Court to direct a verdict in his favor pursuant to his renewed motion for judgment as a matter of law. A hearing on these motions was held before this Court on April 3, 2003.

PLAINTIFFS' MOTION FOR A NEW TRIAL
Rule 59(a) of the Rhode Island Superior Court Rules of Civil Procedure provides that:

"[a] new trial may be granted to all or any of the parties and on all or part of the issues . . . in an action in which there has been a trial by jury for error of law occurring at the trial or for any of the reasons for which new trials have heretofore been granted in actions at law in the courts of this state . . . ."

When considering a motion for a new trial, the trial justice acts as a "super juror," reviewing all of the evidence in light of his or her independent judgment. See Rezendes v. Beaudette, 797 A.2d 474, 477-78 (R.I. 2002). Although the trial justice need not "make an exhaustive analysis of the evidence or state all relevant conclusions about the weight of the evidence or the witnesses' credibility," Rucco v. RhodeIsland Pub. Transit Auth., 525 A.2d 43, 45 (R.I. 1987), he or she must comment on the weight of the evidence and on the credibility of the witnesses. See Rezendes, 797 A.2d at 478.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State v. Sherman
317 A.2d 445 (Supreme Court of Rhode Island, 1974)
Rezendes v. Beaudette
797 A.2d 474 (Supreme Court of Rhode Island, 2002)
Kenny v. Wepman
753 A.2d 924 (Supreme Court of Rhode Island, 2000)
State v. Pailin
339 A.2d 253 (Supreme Court of Rhode Island, 1975)
Flanagan v. Wesselhoeft
712 A.2d 365 (Supreme Court of Rhode Island, 1998)
State v. Werner
140 A.2d 502 (Supreme Court of Rhode Island, 1958)
State v. Mancini
274 A.2d 742 (Supreme Court of Rhode Island, 1971)
Skaling v. Aetna Insurance
742 A.2d 282 (Supreme Court of Rhode Island, 1999)
Long v. Atlantic PBS, Inc.
681 A.2d 249 (Supreme Court of Rhode Island, 1996)
State v. Ouimette
298 A.2d 124 (Supreme Court of Rhode Island, 1972)
Wilkinson v. Vesey
295 A.2d 676 (Supreme Court of Rhode Island, 1972)
State v. Hoyle
404 A.2d 69 (Supreme Court of Rhode Island, 1979)
Rucco v. Rhode Island Public Transit Authority
525 A.2d 43 (Supreme Court of Rhode Island, 1987)
Votolato v. Merandi
747 A.2d 455 (Supreme Court of Rhode Island, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
Baylies v. Doberstein, 97-6046 (2003), Counsel Stack Legal Research, https://law.counselstack.com/opinion/baylies-v-doberstein-97-6046-2003-risuperct-2003.